Nobilis Health Corp is a healthcare company that owns and operates surgical hospitals, ambulatory surgery centers (ASCs), and clinics across five states. The company has a unique direct-to-patient marketing model that drives additional surgical volume to its portfolio of facilities. Nobilis provides a compelling value proposition for physicians, patients, and payors through high-quality and cost-effective care. The company has achieved strong revenue and earnings growth through acquisitions and its marketing strategy, and management aims to continue expanding nationwide.
Nobilis health corporate presentation june 2017IRNobilisHealth
Nobilis Health Corp owns and operates ambulatory surgical centers (ASCs), surgical hospitals, and clinics across 7 states. The company has a unique direct-to-patient marketing model that focuses on physician marketing and a concierge patient experience. For the last twelve months ending March 31, 2017, Nobilis reported revenue of $302.8 million and adjusted EBITDA of $35.6 million. The company's growth strategy focuses on organic growth through marketing and acquisitions in the fragmented ASC industry. Nobilis provides financial guidance for 2017 of $310-325 million in revenue and $40-45 million in adjusted EBITDA.
The document provides an overview of Nobilis Health Corp., including its business model, growth strategy, financial performance, and investment highlights. Specifically:
1) Nobilis owns and operates ambulatory surgical centers and surgical hospitals across multiple states, employing a direct-to-patient marketing model.
2) The company pursues acquisitions of surgical facilities and clinics to expand its geographic footprint and service lines. It focuses on accretive deals that can leverage its marketing capabilities.
3) Nobilis has achieved strong revenue and adjusted EBITDA growth in recent years through both organic growth and acquisitions. It expects this growth trend to continue in 2017 and beyond.
Nobilis corp pres 09.17 cantor fitzgerald conference IRNobilisHealth
Nobilis Health provides a concierge service called 360 Concierge that coordinates patient care from diagnosis through surgery and recovery. The service includes insurance verification, scheduling, and follow up to streamline the patient experience. By controlling the entire process, Nobilis aims to improve outcomes and lower costs for patients, physicians, and insurance companies.
Nobilis Health Corp. presented at the 2017 Cantor Fitzgerald Global Healthcare Conference. The presentation discussed Nobilis' unique patient acquisition model and growth strategy. Some key points:
1) Nobilis utilizes multiple marketing channels and a proprietary technology platform to directly target and acquire patients, driving organic volume growth. This is unlike traditional referral models.
2) Nobilis' growth strategy focuses on continued marketing expertise to generate organic growth, pursuing acquisition opportunities in the fragmented market, and optimizing its case mix to maximize higher-paying procedures.
3) Nobilis operates 4 surgical hospitals, 10 ASCs, and 13 clinics across 5 states, with plans to expand nationwide. The company generated $321 million in revenue
1) Nobilis Health Corp. owns and operates surgical facilities and ambulatory surgery centers across 5 states. It uses various marketing channels to directly generate patient volume and organically grow its business.
2) In 2017, Nobilis Health generated $300 million in revenue and $41 million in adjusted EBITDA. For 2018, it has guided to $345-355 million in revenue and $57-62 million in adjusted EBITDA.
3) Nobilis Health aims to continue growing organically and through acquisitions. Its direct marketing model and ownership of ancillary service lines help maximize revenue and provide a continuum of patient care.
Apollo Medical Holdings (ApolloMed) is a leading integrated healthcare company providing solutions to hospitals, health plans, physicians, and other health providers to provide cost-effective, quality healthcare. We work with providers and hospitals to coordinate care with local primary care physicians to reduce preventable hospital admissions and re-admissions, best in class patient centric care, and avoidable emergency room visits.
Nobilis health corporate presentation march 3.23.18 final[2]IRNobilisHealth
Nobilis Health Corp. is a healthcare company that owns and operates ambulatory surgical centers (ASCs), surgical hospitals, and ancillary services across five states. It has a unique direct-to-consumer marketing model that drives organic patient volume growth. For 2017, Nobilis Health reported $300 million in revenue and $41 million in adjusted EBITDA. The company aims to continue growing organically through marketing and acquiring complementary businesses.
Apollo Medical Holdings (“ApolloMed” or “AMEH”) is a leading population management and physician healthcare delivery company. Apollo provides medical management and care coordination for over 1,000 providers and 40,000 patients; including many senior patients. In addition, Apollo doctors provide care for over 100,000 patients in hospitals, facilities, and clinics. ApolloMed’s integrated healthcare delivery platform is comprised of ApolloMed Hospitalists, ApolloMed ACO (Accountable Care Organization), Maverick Medical Group IPA (Independent Physician Association), Apollo Palliative Services, and ApolloMed Care Clinics. ApolloMed is able to provide high quality, cost-effective care, and its revenue model ranges from traditional volume-based payments to taking full clinical and financial risk for pools of patients.
Nobilis health corporate presentation june 2017IRNobilisHealth
Nobilis Health Corp owns and operates ambulatory surgical centers (ASCs), surgical hospitals, and clinics across 7 states. The company has a unique direct-to-patient marketing model that focuses on physician marketing and a concierge patient experience. For the last twelve months ending March 31, 2017, Nobilis reported revenue of $302.8 million and adjusted EBITDA of $35.6 million. The company's growth strategy focuses on organic growth through marketing and acquisitions in the fragmented ASC industry. Nobilis provides financial guidance for 2017 of $310-325 million in revenue and $40-45 million in adjusted EBITDA.
The document provides an overview of Nobilis Health Corp., including its business model, growth strategy, financial performance, and investment highlights. Specifically:
1) Nobilis owns and operates ambulatory surgical centers and surgical hospitals across multiple states, employing a direct-to-patient marketing model.
2) The company pursues acquisitions of surgical facilities and clinics to expand its geographic footprint and service lines. It focuses on accretive deals that can leverage its marketing capabilities.
3) Nobilis has achieved strong revenue and adjusted EBITDA growth in recent years through both organic growth and acquisitions. It expects this growth trend to continue in 2017 and beyond.
Nobilis corp pres 09.17 cantor fitzgerald conference IRNobilisHealth
Nobilis Health provides a concierge service called 360 Concierge that coordinates patient care from diagnosis through surgery and recovery. The service includes insurance verification, scheduling, and follow up to streamline the patient experience. By controlling the entire process, Nobilis aims to improve outcomes and lower costs for patients, physicians, and insurance companies.
Nobilis Health Corp. presented at the 2017 Cantor Fitzgerald Global Healthcare Conference. The presentation discussed Nobilis' unique patient acquisition model and growth strategy. Some key points:
1) Nobilis utilizes multiple marketing channels and a proprietary technology platform to directly target and acquire patients, driving organic volume growth. This is unlike traditional referral models.
2) Nobilis' growth strategy focuses on continued marketing expertise to generate organic growth, pursuing acquisition opportunities in the fragmented market, and optimizing its case mix to maximize higher-paying procedures.
3) Nobilis operates 4 surgical hospitals, 10 ASCs, and 13 clinics across 5 states, with plans to expand nationwide. The company generated $321 million in revenue
1) Nobilis Health Corp. owns and operates surgical facilities and ambulatory surgery centers across 5 states. It uses various marketing channels to directly generate patient volume and organically grow its business.
2) In 2017, Nobilis Health generated $300 million in revenue and $41 million in adjusted EBITDA. For 2018, it has guided to $345-355 million in revenue and $57-62 million in adjusted EBITDA.
3) Nobilis Health aims to continue growing organically and through acquisitions. Its direct marketing model and ownership of ancillary service lines help maximize revenue and provide a continuum of patient care.
Apollo Medical Holdings (ApolloMed) is a leading integrated healthcare company providing solutions to hospitals, health plans, physicians, and other health providers to provide cost-effective, quality healthcare. We work with providers and hospitals to coordinate care with local primary care physicians to reduce preventable hospital admissions and re-admissions, best in class patient centric care, and avoidable emergency room visits.
Nobilis health corporate presentation march 3.23.18 final[2]IRNobilisHealth
Nobilis Health Corp. is a healthcare company that owns and operates ambulatory surgical centers (ASCs), surgical hospitals, and ancillary services across five states. It has a unique direct-to-consumer marketing model that drives organic patient volume growth. For 2017, Nobilis Health reported $300 million in revenue and $41 million in adjusted EBITDA. The company aims to continue growing organically through marketing and acquiring complementary businesses.
Apollo Medical Holdings (“ApolloMed” or “AMEH”) is a leading population management and physician healthcare delivery company. Apollo provides medical management and care coordination for over 1,000 providers and 40,000 patients; including many senior patients. In addition, Apollo doctors provide care for over 100,000 patients in hospitals, facilities, and clinics. ApolloMed’s integrated healthcare delivery platform is comprised of ApolloMed Hospitalists, ApolloMed ACO (Accountable Care Organization), Maverick Medical Group IPA (Independent Physician Association), Apollo Palliative Services, and ApolloMed Care Clinics. ApolloMed is able to provide high quality, cost-effective care, and its revenue model ranges from traditional volume-based payments to taking full clinical and financial risk for pools of patients.
Assured Pharmacy owns and operates specialty pharmacies that deliver a high level of care, service and compassion for individuals coping with chronic pain.
Personal care physicians series b preferred investment presentationPersonalCare
The concierge medicine industry in the US is estimated at $5 billion and growing 34% annually. PersonalCare helps doctors, health systems, and companies provide optimal healthcare solutions to high-income customers. With over 1,800 paying members across 3 locations, PersonalCare generates over $8 million in annual recurring revenue and is trending towards positive EBITDA in Q4 2015. The company is seeking $1 million in funding to expand into new markets through physician partnerships and management agreements.
Cardinal Health reported financial results for Q3 FY2017 with total revenue of $31.8 billion, up 4% from the previous year. Operating earnings were $605 million, down 8% due to generic drug pricing pressures and investments in IT systems. The outlook for FY2017 expects revenue to increase in the mid-to-high single digit percentage range with non-GAAP diluted EPS expected between $5.24-$5.50. Key assumptions include continued generic drug price deflation, brand drug price inflation, and contributions from acquisitions offset by lower benefits from generic launches and Red Oak Sourcing.
American CareSource Holdings is an owner and operator of urgent care medical centers pursuing an aggressive growth strategy through de novo clinic development and acquisitions. The company aims to have 51 centers by the end of 2017 and 81 centers by 2018. It focuses on operating conveniently located, affordable urgent care clinics in the Southeast U.S. that offer walk-in medical care without appointments. The company sees opportunities to consolidate a fragmented urgent care industry and achieve economies of scale. Its growth strategy relies on developing new clinics, acquiring competitors, and increasing revenue per existing clinic.
Cancer Genetics reported on its Q4 and full year 2016 earnings. Key highlights included 50% revenue growth in 2016 to $27 million, driven by increases in biopharma, clinical, and discovery services. The company realized operational efficiencies through integration of acquisitions, reducing expenses. However, the company reported a net loss of $15.8 million for 2016. In Q4 2016, revenue increased 32% to $7.2 million while expenses decreased, though the company reported a net loss of $2.8 million. Additionally, Cancer Genetics completed a $12 million debt refinancing to repay existing debt and access additional capital.
The document discusses setting up and managing medical affairs teams in the Asia Pacific region. It outlines the role of medical affairs as providing medical leadership, generating and disseminating data, and ensuring pharmacovigilance and compliance. It also discusses establishing the right balance of resources and competencies on regional teams. Key challenges for regional medical affairs teams in Asia Pacific include recruiting talent given diversity across countries, adapting to different healthcare systems, and meeting varied patient and HCP expectations.
Practice Areas: New Product Planning, Business Development and Licensing, Commercial Strategy and Analytics, and Epidemiology and Forecasting.
Our boutique expertise is focused on elucidating patient benefits of bio-pharmaceutical products, medical devices, and businesses. With insightful strategies and solutions aimed at planning and growing our clients’ business, our mission is to continue being the “go-to” firm and preferred partner for our clients in their commercial planning and R&D initiatives.
Our chief operating principle is an unsurpassable commitment to quality and our philosophy has been to develop and sustain strong long-term relationships with clients based on an in-depth understanding of client needs, rigorous research, sound methodologies, and keeping ahead of industry developments.
Diplomat is a specialty pharmacy company that provides concierge services and access to limited distribution drugs. It has experienced exceptional revenue growth of 52% in 2015 and continues to gain market share through strategic acquisitions and partnerships that expand its services, therapeutic expertise and geographic footprint. Diplomat utilizes a unique business model that focuses on specialty drugs and generates higher margins through drug mix shifts toward higher cost therapies and revenue from pharmaceutical manufacturers.
This document provides an introduction and overview of the textbook "COMPREHENSIVE FINANCIAL PLANNING STRATEGIES FOR DOCTORS AND ADVISORS" which aims to provide physician-focused financial planning advice and strategies. The textbook was created by Drs. David Edward Marcinko and Hope Rachel Hetico to address the lack of niche financial planning resources for medical professionals. It presents best practices from leading consultants and draws on their experiences to offer practical guidance. The textbook also serves as part of the curriculum for the Certified Medical Planner certification program.
The document outlines a business plan for starting a medical device supply company in South Africa. It provides an overview of the market opportunity in South Africa, including growth rates in the medical device industry and the types of products sold. It then outlines 7 steps to starting the business, including selecting a niche market, obtaining necessary licenses and permits, setting up inventory, and marketing strategies. Key points about the South African market such as the size of the public and private hospital sector and available financing options are also summarized.
ProMed Alliance International is offering 100 units for $10 million total, with each unit consisting of 10,000 preferred shares, 10,000 common shares, and 10,000 stock options. The minimum investment is 1 unit ($100,000). ProMed Alliance aims to partner with over 300 physicians within 3 years through solutions to improve revenue cycle management, reduce expenses through a group purchasing organization, and develop new profit centers. The goal is to combat low physician satisfaction by streamlining operations and reducing costs.
China Cord Blood Corporation is a leading cord blood banking operator in China, providing storage and processing services. It has the largest market presence among licensed operators, with exclusive operations in Beijing, Guangdong, and Zhejiang provinces, covering 45% of newborns in authorized regions. It has a lucrative recurring revenue model from subscription fees. The company has consistent subscriber growth, substantial profitability, and a strong cash position. It is led by an experienced management team with extensive experience in China's healthcare industry.
Elaj Group is a healthcare organization operating in multiple countries focusing on chronic care delivery. It has medical centers, hospitals, and labs. Elaj uses a combination of generic strategies including cost leadership, differentiation, and focus. Its vision is to provide leading healthcare services in the Middle East and Africa. The mission is to build and operate diagnostic and medical centers/hospitals providing high-quality, affordable services. A PESTEL analysis identified political instability, foreign exchange rate fluctuations, price increases, lifestyle changes, and new technologies as important external factors. Porter's five forces showed competition from other groups, moderate threats from new entrants, and strong supplier relationships.
MedReleaf is a Canadian licensed producer of medical cannabis with a market capitalization of $890 million. It has the largest market share of the Canadian medical cannabis market at 82%. The presentation discusses MedReleaf's strategy of focusing on quality, innovation, and profitability to establish itself as the standard in the medical cannabis industry. It highlights the company's expansion plans, new product development, and growth opportunities in medical cannabis in Canada and international markets.
Canni med therapeutics inc management presentation - march 2017CannimedTherapeutics
CanniMed Therapeutics is a Canadian pharmaceutical company and leader in the medical cannabis industry with 15 years of experience culturing cannabis. It has a GMP-compliant production process with strict quality control and is conducting the first Health Canada approved Phase IIA clinical trial. CanniMed is focused on producing pharmaceutical-grade cannabis products and developing new delivery methods, such as cannabis oil gelcaps, to appeal to broader medical markets for pain treatment. It aims to address the large market for alternative chronic pain therapies and the needs of aging baby boomers.
CanniMed Therapeutics Inc. is a Canadian pharmaceutical company and leader in the medical cannabis industry with 15 years of experience cultivating cannabis. It has GMP-compliant production facilities and a clinical research program. CanniMed raised $69 million in its IPO to fund expansion and clinical trials to validate medical cannabis for pain relief. It focuses on pharmaceutical-grade products including cannabis oils to address the needs of the growing medical cannabis market and aging population seeking pain treatment alternatives.
Nobilis health corporate presentation august 2017 2IRNobilisHealth
Nobilis Health Corp. utilizes a unique direct-to-patient marketing model to drive additional surgical volume to its portfolio of facilities. The model involves targeting prospective patients through multiple marketing channels and providing a personalized concierge service. This generates higher acuity cases and a scalable revenue stream while offering physicians an opportunity to expand their practices. Nobilis owns and operates surgical hospitals, ambulatory surgery centers, and clinics across five states, utilizing its marketing expertise and portfolio approach to maximize returns.
This corporate presentation provides an overview of Nobilis Health Corp., a full-service healthcare development and management company. Some key points:
- Nobilis owns and manages 4 surgical hospitals and 5 ASCs across 7 states, and partners with 36 additional facilities.
- They utilize a direct-to-patient marketing model and proprietary technology platform to generate leads and efficiently coordinate patient care.
- Nobilis has an optimized mix of profitable procedures and commercial payors. They are also pursuing bundled payment programs through their Concertis subsidiary.
- The company has achieved strong revenue and EBITDA growth through acquisitions and organic growth of existing facilities. Management projects continued expansion in the coming years.
This corporate presentation provides an overview of Nobilis Health Corp., a full-service healthcare development and management company. Some key points:
- Nobilis owns and manages 4 surgical hospitals and 5 ASCs across 7 states, and partners with 36 additional facilities.
- They utilize a direct-to-patient marketing model and proprietary technology platform to generate leads and efficiently coordinate patient care.
- Nobilis has an optimized mix of profitable procedures and commercial payors. They are also pursuing bundled payment programs through their Concertis subsidiary.
- The company has achieved strong revenue and EBITDA growth through acquisitions and organic growth of existing facilities. Management projects continued expansion in the coming years.
- Nobilis Health Corp owns and operates ambulatory surgical centers and surgical hospitals across 7 states.
- They utilize a unique direct-to-patient marketing model to drive organic growth and capitalize on the trend of increased healthcare consumerism.
- For 2015, Nobilis reported revenue of $229.2 million and adjusted EBITDA of $42.1 million. They expect continued growth through organic expansion and acquisitions in a fragmented market.
- Nobilis Health Corp owns and operates ambulatory surgical centers (ASCs) and surgical hospitals. It has a unique direct-to-patient marketing model.
- In 2015 it reported revenue of $229.2 million and adjusted EBITDA of $42.1 million. It is focused on organic growth and acquisitions in a fragmented market.
- Its direct marketing approach drives higher case volumes and it capitalizes on the trend of increased outpatient procedures. It aims to continue growing revenue and adjusted EBITDA over 20% organically through 2016.
The document provides an overview of Nobilis Health Corp., a healthcare development and management company. It summarizes Nobilis' business model, including owning and managing surgical hospitals and ASCs across multiple markets. It highlights Nobilis' direct marketing model, optimized case mix, revenue cycle management platform, and technology platform. The document also discusses Nobilis' growth strategy of acquisitions and physician marketing to drive continued revenue and earnings growth.
Assured Pharmacy owns and operates specialty pharmacies that deliver a high level of care, service and compassion for individuals coping with chronic pain.
Personal care physicians series b preferred investment presentationPersonalCare
The concierge medicine industry in the US is estimated at $5 billion and growing 34% annually. PersonalCare helps doctors, health systems, and companies provide optimal healthcare solutions to high-income customers. With over 1,800 paying members across 3 locations, PersonalCare generates over $8 million in annual recurring revenue and is trending towards positive EBITDA in Q4 2015. The company is seeking $1 million in funding to expand into new markets through physician partnerships and management agreements.
Cardinal Health reported financial results for Q3 FY2017 with total revenue of $31.8 billion, up 4% from the previous year. Operating earnings were $605 million, down 8% due to generic drug pricing pressures and investments in IT systems. The outlook for FY2017 expects revenue to increase in the mid-to-high single digit percentage range with non-GAAP diluted EPS expected between $5.24-$5.50. Key assumptions include continued generic drug price deflation, brand drug price inflation, and contributions from acquisitions offset by lower benefits from generic launches and Red Oak Sourcing.
American CareSource Holdings is an owner and operator of urgent care medical centers pursuing an aggressive growth strategy through de novo clinic development and acquisitions. The company aims to have 51 centers by the end of 2017 and 81 centers by 2018. It focuses on operating conveniently located, affordable urgent care clinics in the Southeast U.S. that offer walk-in medical care without appointments. The company sees opportunities to consolidate a fragmented urgent care industry and achieve economies of scale. Its growth strategy relies on developing new clinics, acquiring competitors, and increasing revenue per existing clinic.
Cancer Genetics reported on its Q4 and full year 2016 earnings. Key highlights included 50% revenue growth in 2016 to $27 million, driven by increases in biopharma, clinical, and discovery services. The company realized operational efficiencies through integration of acquisitions, reducing expenses. However, the company reported a net loss of $15.8 million for 2016. In Q4 2016, revenue increased 32% to $7.2 million while expenses decreased, though the company reported a net loss of $2.8 million. Additionally, Cancer Genetics completed a $12 million debt refinancing to repay existing debt and access additional capital.
The document discusses setting up and managing medical affairs teams in the Asia Pacific region. It outlines the role of medical affairs as providing medical leadership, generating and disseminating data, and ensuring pharmacovigilance and compliance. It also discusses establishing the right balance of resources and competencies on regional teams. Key challenges for regional medical affairs teams in Asia Pacific include recruiting talent given diversity across countries, adapting to different healthcare systems, and meeting varied patient and HCP expectations.
Practice Areas: New Product Planning, Business Development and Licensing, Commercial Strategy and Analytics, and Epidemiology and Forecasting.
Our boutique expertise is focused on elucidating patient benefits of bio-pharmaceutical products, medical devices, and businesses. With insightful strategies and solutions aimed at planning and growing our clients’ business, our mission is to continue being the “go-to” firm and preferred partner for our clients in their commercial planning and R&D initiatives.
Our chief operating principle is an unsurpassable commitment to quality and our philosophy has been to develop and sustain strong long-term relationships with clients based on an in-depth understanding of client needs, rigorous research, sound methodologies, and keeping ahead of industry developments.
Diplomat is a specialty pharmacy company that provides concierge services and access to limited distribution drugs. It has experienced exceptional revenue growth of 52% in 2015 and continues to gain market share through strategic acquisitions and partnerships that expand its services, therapeutic expertise and geographic footprint. Diplomat utilizes a unique business model that focuses on specialty drugs and generates higher margins through drug mix shifts toward higher cost therapies and revenue from pharmaceutical manufacturers.
This document provides an introduction and overview of the textbook "COMPREHENSIVE FINANCIAL PLANNING STRATEGIES FOR DOCTORS AND ADVISORS" which aims to provide physician-focused financial planning advice and strategies. The textbook was created by Drs. David Edward Marcinko and Hope Rachel Hetico to address the lack of niche financial planning resources for medical professionals. It presents best practices from leading consultants and draws on their experiences to offer practical guidance. The textbook also serves as part of the curriculum for the Certified Medical Planner certification program.
The document outlines a business plan for starting a medical device supply company in South Africa. It provides an overview of the market opportunity in South Africa, including growth rates in the medical device industry and the types of products sold. It then outlines 7 steps to starting the business, including selecting a niche market, obtaining necessary licenses and permits, setting up inventory, and marketing strategies. Key points about the South African market such as the size of the public and private hospital sector and available financing options are also summarized.
ProMed Alliance International is offering 100 units for $10 million total, with each unit consisting of 10,000 preferred shares, 10,000 common shares, and 10,000 stock options. The minimum investment is 1 unit ($100,000). ProMed Alliance aims to partner with over 300 physicians within 3 years through solutions to improve revenue cycle management, reduce expenses through a group purchasing organization, and develop new profit centers. The goal is to combat low physician satisfaction by streamlining operations and reducing costs.
China Cord Blood Corporation is a leading cord blood banking operator in China, providing storage and processing services. It has the largest market presence among licensed operators, with exclusive operations in Beijing, Guangdong, and Zhejiang provinces, covering 45% of newborns in authorized regions. It has a lucrative recurring revenue model from subscription fees. The company has consistent subscriber growth, substantial profitability, and a strong cash position. It is led by an experienced management team with extensive experience in China's healthcare industry.
Elaj Group is a healthcare organization operating in multiple countries focusing on chronic care delivery. It has medical centers, hospitals, and labs. Elaj uses a combination of generic strategies including cost leadership, differentiation, and focus. Its vision is to provide leading healthcare services in the Middle East and Africa. The mission is to build and operate diagnostic and medical centers/hospitals providing high-quality, affordable services. A PESTEL analysis identified political instability, foreign exchange rate fluctuations, price increases, lifestyle changes, and new technologies as important external factors. Porter's five forces showed competition from other groups, moderate threats from new entrants, and strong supplier relationships.
MedReleaf is a Canadian licensed producer of medical cannabis with a market capitalization of $890 million. It has the largest market share of the Canadian medical cannabis market at 82%. The presentation discusses MedReleaf's strategy of focusing on quality, innovation, and profitability to establish itself as the standard in the medical cannabis industry. It highlights the company's expansion plans, new product development, and growth opportunities in medical cannabis in Canada and international markets.
Canni med therapeutics inc management presentation - march 2017CannimedTherapeutics
CanniMed Therapeutics is a Canadian pharmaceutical company and leader in the medical cannabis industry with 15 years of experience culturing cannabis. It has a GMP-compliant production process with strict quality control and is conducting the first Health Canada approved Phase IIA clinical trial. CanniMed is focused on producing pharmaceutical-grade cannabis products and developing new delivery methods, such as cannabis oil gelcaps, to appeal to broader medical markets for pain treatment. It aims to address the large market for alternative chronic pain therapies and the needs of aging baby boomers.
CanniMed Therapeutics Inc. is a Canadian pharmaceutical company and leader in the medical cannabis industry with 15 years of experience cultivating cannabis. It has GMP-compliant production facilities and a clinical research program. CanniMed raised $69 million in its IPO to fund expansion and clinical trials to validate medical cannabis for pain relief. It focuses on pharmaceutical-grade products including cannabis oils to address the needs of the growing medical cannabis market and aging population seeking pain treatment alternatives.
Nobilis health corporate presentation august 2017 2IRNobilisHealth
Nobilis Health Corp. utilizes a unique direct-to-patient marketing model to drive additional surgical volume to its portfolio of facilities. The model involves targeting prospective patients through multiple marketing channels and providing a personalized concierge service. This generates higher acuity cases and a scalable revenue stream while offering physicians an opportunity to expand their practices. Nobilis owns and operates surgical hospitals, ambulatory surgery centers, and clinics across five states, utilizing its marketing expertise and portfolio approach to maximize returns.
This corporate presentation provides an overview of Nobilis Health Corp., a full-service healthcare development and management company. Some key points:
- Nobilis owns and manages 4 surgical hospitals and 5 ASCs across 7 states, and partners with 36 additional facilities.
- They utilize a direct-to-patient marketing model and proprietary technology platform to generate leads and efficiently coordinate patient care.
- Nobilis has an optimized mix of profitable procedures and commercial payors. They are also pursuing bundled payment programs through their Concertis subsidiary.
- The company has achieved strong revenue and EBITDA growth through acquisitions and organic growth of existing facilities. Management projects continued expansion in the coming years.
This corporate presentation provides an overview of Nobilis Health Corp., a full-service healthcare development and management company. Some key points:
- Nobilis owns and manages 4 surgical hospitals and 5 ASCs across 7 states, and partners with 36 additional facilities.
- They utilize a direct-to-patient marketing model and proprietary technology platform to generate leads and efficiently coordinate patient care.
- Nobilis has an optimized mix of profitable procedures and commercial payors. They are also pursuing bundled payment programs through their Concertis subsidiary.
- The company has achieved strong revenue and EBITDA growth through acquisitions and organic growth of existing facilities. Management projects continued expansion in the coming years.
- Nobilis Health Corp owns and operates ambulatory surgical centers and surgical hospitals across 7 states.
- They utilize a unique direct-to-patient marketing model to drive organic growth and capitalize on the trend of increased healthcare consumerism.
- For 2015, Nobilis reported revenue of $229.2 million and adjusted EBITDA of $42.1 million. They expect continued growth through organic expansion and acquisitions in a fragmented market.
- Nobilis Health Corp owns and operates ambulatory surgical centers (ASCs) and surgical hospitals. It has a unique direct-to-patient marketing model.
- In 2015 it reported revenue of $229.2 million and adjusted EBITDA of $42.1 million. It is focused on organic growth and acquisitions in a fragmented market.
- Its direct marketing approach drives higher case volumes and it capitalizes on the trend of increased outpatient procedures. It aims to continue growing revenue and adjusted EBITDA over 20% organically through 2016.
The document provides an overview of Nobilis Health Corp., a healthcare development and management company. It summarizes Nobilis' business model, including owning and managing surgical hospitals and ASCs across multiple markets. It highlights Nobilis' direct marketing model, optimized case mix, revenue cycle management platform, and technology platform. The document also discusses Nobilis' growth strategy of acquisitions and physician marketing to drive continued revenue and earnings growth.
2 015
A N N U A L
R E P O R T
This year at Johnson & Johnson, we are proud
to celebrate 130 years of helping people
everywhere live longer, healthier and happier
lives. As I reflect on our heritage and consider
our future, I am optimistic and confident in the
long-term potential for our business.
We manage our business using a strategic
framework that begins with Our Credo. Written
over 70 years ago, it unites and inspires the
employees of Johnson & Johnson. It reminds
us that our first responsibility is to the patients,
customers and health care professionals who
use our products, and it compels us to deliver
on our responsibilities to our employees,
communities and shareholders.
Our strategic framework positions us well
to continue our leadership in the markets in
which we compete through a set of strategic
principles: we are broadly based in human
health care, our focus is on managing for the
long term, we operate under a decentralized
management approach, and we do all
this aligned with our values. Our Board of
Directors engages in a formal review of
our strategic plans, and provides regular
guidance to ensure our strategy will continue
creating better outcomes for the patients
and customers we serve, while also creating
long-term value for our shareholders.
OUR STRATEGIES ARE BASED ON
OUR BROAD AND DEEP KNOWLEDGE
OF THE HEALTH CARE LANDSCAPE
IN WHICH WE OPERATE.
For 130 years, our company has been
driving breakthrough innovation in health
care – from revolutionizing wound care in
the 1880s to developing cures, vaccines
and treatments for some of today’s most
pressing diseases in the world. We are acutely
aware of the need to evaluate our business
against the changing health care environment
and to challenge ourselves based on the
results we deliver. Consider some of the
changes we are facing in the future global
health care market:
WRITTEN OVER
70 YEARS AGO,
OUR CREDO
UNITES &
INSPIRES THE
EMPLOYEES
OF JOHNSON
& JOHNSON.
MARCH 2016
TO OUR
SHAREHOLDERS
ALEX GORSKY
Chairman, Board of Directors
and Chief Executive Officer
aging rapidly – and we know the elderly
consume about seven times the health
care resources as younger people.
developing nations – and we know that
those developing economies cannot grow
fast enough to meet the demand of nearly
two billion people who want and deserve
greater access to quality health care.
involved in their own health care decisions
– and we know we must deliver a holistic
approach to meet their needs and
expectations; integrating wellness solutions,
innovative new medicines and advanced
technologies.
At Johnson & Johnson, we believe the
most important contribution we can make
to the dynamic challenges we are facing is
innovation – innovation in products, services,
solutions and in everything we do. As I think
back on how far we’ve come, the ...
Measuring Physician Relations ROI; Tools & TechniquesRenown Health
The document describes a workshop on measuring physician relations return on investment. It discusses how three organizations, including Baystate Health, demonstrate results from their physician relations programs. At Baystate Health, their physician liaison program led to $8 million in new annual revenue, a 25 to 1 return on their $316,000 investment. Their liaisons conduct over 1,400 face-to-face visits annually and help fill new specialist panels 50% faster. The workshop aims to help others learn from these examples on tracking measures that align with goals and demonstrating physician relations program value.
Medical Facilities Corporation - 2019 Annual ReportSharePitch
MFC remains well aligned for one of the major trends in U.S. healthcare, which has been the growing number of
surgical procedures that are being performed in outpatient settings. Additionally, the demand for health care services
continues to grow, as a result of a growing and aging population, as well as increasing in breadth and scope of
procedures, such as knee replacement surgery.
View the full HTML version of the report at https://2019ar.medicalfacilitiescorp.ca/wp-content/uploads/2020/04/MFC-2019-Print-Annual-2020-04-03a.pdf
Medical Facilities' common shares trade on the TSX under the symbol DR.
Running head HEALTHCARE CARE NEEDS AND REAL COMPETITION 1HE.docxjeanettehully
Red Clay Renovations is a privately held home remodeling company incorporated in Delaware in 1991. It has offices in Baltimore, Philadelphia, and Wilmington and specializes in smart home renovations. The company is governed by a five-member board of directors and led by a CEO, CFO, COO, and various directors. It recently hired a new Director of IT Services and CISO to improve its IT security program.
- Kenneth J. Barker is a seasoned CEO, board member, and committee chair with decades of experience in healthcare professional accounting, business leadership, and management consulting.
- He has held senior executive roles including interim Chief Compliance Officer at Tenet Healthcare, where he assessed compliance functions and designed modifications to executive bonus plans.
- Barker also served as Senior Managing Director and Health Solutions Segment Leader at FTI Consulting, where he grew the healthcare practice substantially in partners, professionals, profit, and industry recognition.
Ralph M. Costanzo is an accomplished physician leader who currently serves as Chief Medical Officer at Alaska Regional Hospital. He has over 23 years of experience as an orthopedic hand surgeon and recently completed an MHA. His experience includes serving as Chairman of the Orthopedics Department and on the Board of Directors at St. Vincent Healthcare. He also previously served as President of Ortho Montana, a large orthopedic practice group.
Silicon Valley Bank's Life Science and Healthcare Startup Outlook Report examines how the industry's executives view 2017's opportunities and challenges. The report includes startups' thoughts on public policy issues as well as their expectations for fundraising and hiring.
This document provides a summary of Lori A. Coyle's experience and qualifications. She has over 20 years of experience in executive management, healthcare administration, and legal counsel roles. Her experience includes positions as Executive Director, Director, Practice Administrator, Vice President, and In-House Counsel at various healthcare organizations. She has a strong background in strategic planning, operations management, financial management, and human resources.
This is our Parkway Healthcare Ventures Overview. We are answering the cry for healthcare in rural America. In the process, we have also developed a demonstratively different investment opportunity. Everyone wins with our solution; the physicians looking to sell their practices in rural America, the patients that live in rural America that are lacking enhanced medical care with a variety of modalities and our investors. We offer an investment opportunity in healthcare using an interest bearing convertible note.
Please contact me for more details.
David Federico
david@parkwayhealthcareventures.com
770 713.1243
In January 2013, Catholic Health Initiatives began a multi-phase journey to develop a population health management solution across all of its regions. This presentation will describe the strategies the health system pursued for: creating a clinically integrated network as a first step in managing the health of populations and integrating care across the patient experience; aligning hospitals and physician groups to create successful clinical models; creating a data platform to share clinical measures and benchmarks; and ultimately becoming a risk-bearing shared savings ACO. Participants will hear real-world examples of best practices for how to meet FTC regulations, create an effective governance structure to manage performance, and align financial incentives. Learn how one of the nation's largest hospital systems developed a system-wide population health management solution in order to achieve the necessary transformation from fee-for-service to fee-for-value.
This document provides a summary of Marlene A. Wise's professional experience and qualifications. She has over 25 years of experience in healthcare management, business development, and operations leadership roles within hospice, home health, skilled nursing facilities, and assisted living organizations. Her background includes developing new programs, managing multi-million dollar budgets, and achieving growth objectives through strategic planning and relationship building. She has a track record of success developing and leading healthcare organizations and teams.
Interim leadership as a career path webinarMichael Lieb
Are you considering Interim work as a Career Path? If so, HealthTechS3 would like to talk to you. Join our pool of professional Interim Leaders at
http://www.healthtechs3.com/careers/
Arnie albert sr. healthcare leader resume 05. 2012Arnie Albert
Arnie Albert has over 25 years of experience leading healthcare operations and business development. He has a track record of growing revenues and improving financial and clinical outcomes across multiple healthcare organizations. Albert is skilled in strategic planning, process improvement, team leadership, and managing clinical, financial and administrative operations. He has experience integrating new acquisitions and managing multi-site practices across various healthcare settings.
Similar to Nobilis health corporate presentation august 2017 (20)
UnityNet World Environment Day Abraham Project 2024 Press ReleaseLHelferty
June 12, 2024 UnityNet International (#UNI) World Environment Day Abraham Project 2024 Press Release from Markham / Mississauga, Ontario in the, Greater Tkaronto Bioregion, Canada in the North American Great Lakes Watersheds of North America (Turtle Island).
ZKsync airdrop of 3.6 billion ZK tokens is scheduled by ZKsync for next week.pdfSOFTTECHHUB
The world of blockchain and decentralized technologies is about to witness a groundbreaking event. ZKsync, the pioneering Ethereum Layer 2 network, has announced the highly anticipated airdrop of its native token, ZK. This move marks a significant milestone in the protocol's journey, empowering the community to take the reins and shape the future of this revolutionary ecosystem.
Methanex is the world's largest producer and supplier of methanol. We create value through our leadership in the global production, marketing and delivery of methanol to customers. View our latest Investor Presentation for more details.
Cleades Robinson, a respected leader in Philadelphia's police force, is known for his diplomatic and tactful approach, fostering a strong community rapport.
World economy charts case study presented by a Big 4
World economy charts case study presented by a Big 4
World economy charts case
World economy charts case study presented by a Big 4
World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4
World economy charts case study presented by a Big 4
World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4study presented by a Big 4
2. Forward-Looking Information
This presentation contains forward-looking information (within the meaning of applicable securities laws)
relating to the business of Nobilis Health Corp. (the "Company") and the environment in which it
operates. Forward-looking information may include statements regarding the objectives, business
strategies to achieve those objectives, expected financial results, economic or market conditions,
industry specific information, and the outlook of or involving the Company and its business. Such forward
looking information or statements are typically identified by words such as "believe", "anticipate",
"expect", "intend", "plan", "will", "may" and other similar expressions.
Forward-looking information, including any financial outlooks, is provided for the purpose of providing
information about management's expectations and plans about the future and may not be appropriate for
other purposes. Forward-looking information herein is based on various assumptions and expectations
that the Company believes are reasonable in the circumstances. No assurance can be given that these
assumptions and expectations will prove to be correct and the forward-looking information, including the
financial outlooks included in this Presentation, should not be unduly relied upon. Those assumptions
and expectations are based on information currently available to the Company, including the historic
performance of the Company's business. Such assumptions include anticipated financial performance,
current business, industry and economic trends, and business prospects and are subject to the risks and
uncertainties which are discussed in the Company's regulatory filings available on the Company's web
site at www.NobilisHealth.com, www.sec.gov, or at www.sedar.com. Any forward-looking statements that
we make are based on assumptions as of today, and we undertake no obligation to update them.
The Company’s management has approved the financial outlooks contained in this presentation.
2
3. Nobilis at a Glance
3
o Based in Houston, TX, Nobilis is an owner, operator, and manager
of Surgical Hospitals, ASCs and Clinics
• Founded in 2007 and now operates in 10 markets across 5
states totaling 24 facilities
o Facilities - 4 surgical hospitals, 10 ASCs, 10 clinics, and 35 partner
facilities
o Core strategy - optimized case mix across the portfolio
• Higher acuity procedures, higher levels of reimbursement
• Focus on minimally invasive procedures
o Unique direct-to-patient marketing model
• Brand procedures and drive additional surgical volume to
portfolio of facilities
• Consumerism - capitalizes on this growing trend in healthcare
• Drives organic growth
o Strong, scalable platform to expand to nationwide player
o Compelling value proposition for physicians, patients, and payors
Company Overview Geographic Locations
Markets with Nobilis
owned facilities
Markets with Nobilis
partner facilities
Established reputation
for high quality patient
care, utilizing state-of-
the-art technology
Strong management team
with proven track record of
successfully integrating
newly acquired businesses
Unique direct-to-patient
marketing model that drives
additional surgical volume
to Nobilis facilities
$321 million in Revenue
and $37 million in Adjusted
EBITDA for LTM June 2017
with low capex requirements
Key Company Highlights
4. Nobilis Business Overview
4
Case Mix
Case Volume
Payor Mix
Note: Unless otherwise dated, figures are based on the LTM period ended 6/30/2017, pro forma for the full year impact of the AZ Vein acquisition.
Note 2: Case mix based on number of cases; payor mix based on revenue.
ENT 4% General
Surgery 4%
Ortho 7%
Pain 27%
Spine 18%
Bariatrics 21%
Plastic
Surgery 10%
GYN 3%
Other 7%
AETNA 20%
BCBS 17%
CIGNA
9%
UHC 34%
Other
Commercial 12%
Self Pay 5% WC 3% Medicare 1%
8,740
17,814
20,459
25,190
-
5,000
10,000
15,000
20,000
25,000
30,000
2014 2015 2016 2017 E
5. 5
Historical Performance
Total Revenue Adj. EBITDA
$31
$84
$229
$286
$0
$50
$100
$150
$200
$250
$300
2013 2014 2015 2016
Revenue (Millions)
$3
$10
$40
$34
$0
$10
$20
$30
$40
$50
2013 2014 2015 2016
Adj. EBITDA (Millions)
Strong Track Record of Revenue and Adj. EBITDA Growth
2016 - Year of Investment
6. Management Team
o Joined Nobilis in 2010
o Previously served as CFO, President and Executive Chairman of Nobilis
o Earned an MBA from Boston College, a J.D. from the University of Houston, and a B.A. from the
University of St. Thomas
6
Harry Fleming
Chief Executive Officer
Kenneth Efird
President
David Young
Chief Financial Officer
Patrick Yoder
Chief Revenue Officer
Marissa Arreola
Chief Strategy Officer &
President of Concertis
o Joined Nobilis in 2010
o Previously served as Chief Operating Officer & Chief Business Development Officer at Nobilis
o Founder & CEO of Diagnostic and Interventional Spine Centers
o Doctorate from Texas Chiropractic College
o Joined Nobilis in 2017
o Previously served as Divisional CFO for St. Jude Medical’s America division
o Licensed CPA
o Earned an MBA from the University of Texas at Austin
o Joined Nobilis in 2014
o 15 years of healthcare sales and business development
o Previously held successful sales leadership positions at Intuitive Surgical, Medtronic, and Pfizer
o Earned a B.A. from Rhodes College
o Joined Nobilis in 2016
o Partner at Baker Donelson, specializing in health law and served as a Director at Houston Methodist
Hospital System
o Earned a J.D. from the University of Houston and B.A. from Rice University
7. Management Team (Cont’d)
o Joined Nobilis in 2015
o Previously served as CFO at Northstar Healthcare LLC and Nobilis
o 20 years of financial and accounting reporting in the healthcare industry
o Earned an M.B.A. from Texas Woman’s University and a B.S. from Sacred Heart University
7
Kenneth Klein
CFO of Operations
Phil Ayres
VP of Marketing
o Joined Nobilis in 2017
o Previously served as Director of Marketing for Travelocity and Director of Online Marketing at
Hotels.com
o Earned a J.D. from University of Tennessee College of Law and a B.S. from Vanderbilt University
Marc Celia
EVP of Operations
o Joined Nobilis in 2017
o 20 years of operational and managerial experience in the healthcare industry
o VP of Continuous Improvement for United Surgical Partners International/ Tenet Healthcare
(“USPI”) and CEO of Memorial Hermann Surgical Hospital Kingwood, in Houston, Texas
o Earned a B.S. from Boston University and a M.S. from University of Maryland
Marcos Rodriguez
Chief Accounting Officer
o Joined Nobilis in 2016
o Began his career at Deloitte & Touche LLP and served five years as Director at Opportune LLP
o 19 years of financial and accounting reporting, external and internal audits, and SEC regulations
o Earned a B.S. from Louisiana State University and is a licensed CPA
Brandon Moreno
VP of Finance
o Joined Nobilis in 2014
o 10 years of finance and accounting experience in the healthcare industry,
including HCA and Tenet
o Earned an M.B.A. from University of Texas – San Antonio and a B.S. from New
York University
8. Key Investment Considerations
o 66% of all surgeries are outpatient with >50% performed in ASCs vs. 32% in 2005
o Lower cost, high quality outpatient setting; trend toward increased consumerism in healthcare
o Abundance of desirable acquisition opportunities due to fragmented market
8
Attractive Industry
Fundamentals
Unique Marketing Model
Favorable Payor and
Procedure Mix
Patient-Centric Value
Proposition
Attractive Financial Profile
Experienced Management
Team
o Multiple marketing channels drive volume growth
o Proprietary technology platform targets prospective patients
o Strong value proposition: Superior patient experience that expands physicians’ practices
o Marketing segment targets higher acuity cases resulting in a highly attractive case mix
o Procedure diversification increases the stability of the revenue base
o Unique marketing model increases case volumes and provides superior patient experience
o Offer optimal surgical environments that result in better overall quality of care
o Offer ancillary and complementary services that lead to better efficiency and better outcomes
o Low leverage
o Low capital expenditure requirements
o Strong management team with M&A and healthcare experience
o Seasoned Ops team leads to financial and operation efficiencies
o Strong in-house and outside legal team to safely navigate complex healthcare space
10. Surgical Setting Background
Traditional Hospitals
o Full-service hospital
o Inpatient and outpatient
o > 5,700 hospitals
o 60%+ not-for-profit
Specialty Surgical
Hospitals (SSHs)
o Typically specialize in
orthopedics, spine, ENT
o Inpatient and outpatient
o ~ 300 SSHs
Ambulatory Surgical
Centers (ASCs)
o Outpatient only
o > 5,500 ASCs
o 70%+ owned by
independents
10
Source: Becker’s.
11. Growth of the ASC Industry
o Estimated at $32 billion, the ASC industry is expected to continue
robust growth due to efficient cost structures and increased
government focus on healthcare
• Industry revenues to expected grow 7.5% as the population ages
and the newly insured access care, reaching $40 billion annually
o Despite recent consolidation activity, the ASC industry remains highly
fragmented
• Independent operators, hospitals and small chains comprise 78%
of the 5,500 ASCs in the U.S., while the eight largest ASC
owner/operators comprise ~22% of the overall market
o Economies of scale drive partnership decision for physician-owned
practices
• Major operators can provide ancillary and complementary
services, normally outsourced to third-party providers, leading to
greater efficiency and better outcomes, while controlling costs
and diversifying service offerings
Source: CSM, Equity Research, IBIS healthcare expenditures estimates, Becker’s.
Projected ASC Industry Revenue
Outpatient Surgeries Moving to ASCs: 1981 to 2016
($ in billions)
11
Factors Influencing ASC/SSH Demand
Steady reimbursement
rates from government
payors support a stable
operating environment at
ASCs & SSHs
Increased ASC/SSH Abilities
Government Funding
Advances in surgical
techniques & technology
have increased the number
& types of outpatient
procedures driving higher
patient volumes
As the economy improves,
greater disposable income
will enable patients to
better afford out-of-pocket
expenses at ASCs &
SSHs
Disposable Income
Growing Insured Population
The insured population
is expected to grow 2%
annually through 2017
$16 $17
$19 $20 $21 $22 $23
$25
$27
$30
$32
$34 $36
$38
$40
$0
$5
$10
$15
$20
$25
$30
$35
$40
$45
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015E
2016E
2017E
2018E
2019E
2020E
ASCs, 6%
Hospital
Outpatient,
84%
ASCs, 50%
Hospital
Outpatient,
50%
12. 27%
17% 17%
13%
10% 9%
4% 3% 2% 1%
0%
5%
10%
15%
20%
25%
30%
GI
Ortho.
Optha.
Pain
Other
ENT
Plastic
Podi.
Urol.
Neuro.
Dynamics Driving Industry Growth
o Case volume at ASCs is projected to increase by 9 - 12%
through 2025
o There are 5,500 ASCs across the U.S., and 90% have some
degree of physician ownership
o Many ASCs focus on elective procedures which are common
in affluent urban and suburban areas with large proportions of
commercially insured patients
o Nobilis’ focus is on the 40% of the market with higher
reimbursement
Specialty Procedures
Orthopedics
Knee arthroscopy, carpal tunnel, rotator cuff
repair, incise finger tendon sheath and wrist
endoscopy
Pain
Management
Injection lumbar / sacral, injection cervical,
thoracic and destruction neurolytic agent
Bariatrics
Gastric bypass, sleeve gastrectomy,
adjustable gastric band, biliopancreatic
diversion with duodenal switch
Source: Wall Street Research, Becker’s.
12
Average ASC Industry Payor Mix
Industry Dynamics ASC Industry Specialty Mix
Top Procedures
Nobilis Key
Procedures
67%
18%
11%
4%
0%
10%
20%
30%
40%
50%
60%
70%
80%
Commercial Medicare FFS Worker's Comp
/ Other
Medicaid
13. Advanced Imaging 13%
Arthrocentesis / Injections
5%
Rehab & Chiropractic
14%
Standard Imaging
13%
E&MVisits
17%
Fusion Surgery
Spinal Decom. / Laminec.
Vertebral Augmentation
23%
27%
25%17%
-9%
-5%
-2%
2%
Less Complex Procedures Shift to Outpatient
o Less complex spine procedures shifting from inpatient to outpatient with significant estimated growth potential
o Key spine procedures have stronger tailwinds due to demographics and improvements in technology
o ~31 million Americans experience back pain at any given time
o ~600,000 Americans undergo spine surgery every year
Lumbar / Thoracic Fusion
Cervical Fusion
No Procedure and
Diagnostics
Spinal Decompression/
Laminectomy
Vertebral Augmentation
Procedures
Revision Spinal Procedure
Note: Growth rate data reflects U.S. market. 13
Source: Wall Street Research.
-11%
Inpatient Spine Discharges 2014 – 2019 Outpatient Spine Volumes 2014 – 2019
Nobilis Key
Procedures
17. Unique Patient Acquisition Strategy
17
Nobilis Brands
Lead Generation Concierge Service
§ Inside sales team and IT platform
to maximize patient experience
§ 9 brands marketed directly to
patients via omni-channel
marketing strategy
Patient Tracking Conversion to Surgical Patient
§ Patient education, medical
review, insurance verification,
and surgical scheduling
§ Patient follow-up, experience
surveys, and referrals
o Marketing and technology platform that targets prospective patients
o Unique value proposition to physicians; superior patient experience
o Generates higher acuity cases vs. traditional referral model
o Scalable revenue driver
o Portfolio effect: direct cases to specific facilities on a procedure-by-
procedure basis for best return
o In-house marketing team works one-on-one with physicians to
develop and distribute customized marketing plans
o Build and execute marketing plans on behalf of physicians
o Helps to expand physicians’ practices, while also driving
additional volume to facilities
o High average ROI
Direct-to-Consumer Marketing Physician Sales
High-Touch Marketing Model
18. Ancillary Services
Nobilis began providing ancillary services in 2015 and has continued expanding its ancillary service
offerings with the addition of clinical lab testing services in 2016 and physical therapy in 2017
o Nobilis began offering lab
services for patients
through Hermann Drive
Surgical Hospital (HDSH)
in September 2016
o Set up to process
~4,000 tests on a
monthly basis
First Assist (Staffing)
o Cover 100% of
outpatient spine cases
through qualifying DTC
o Specialties: Spine,
Bariatrics, ENT,
Orthopedic, Plastic,
General
o Focused on spine procedures
o 100% of DTC cases
o 7 States
o 44 Different Facilities (Both
Nobilis and non-Nobilis
Facilities)
o Specialties: Spine, Neuro,
Ortho, CV, ENT
o Covers most NHC
facilities
o Helps recruit partner
physicians
o Specialties: Spine,
Bariatrics, ENT,
Orthopedic, Plastic,
General
o Nobilis launched Physical
Therapy Services in April
2017 as a Hospital
Outpatient Department of
Plano Surgical Hospital
o Provides patients and
physicians with a partner
in the continuum of care
18
Laboratory Neuromonitoring Anesthesia Physical Therapy
o Nobilis is actively seeking potential M&A
targets in the ancillary services space
o Typically focus on acquisitions with
revenue potential system wide
o Increased capabilities position Nobilis to
execute alternative payment
methodologies for payors
o 2016 revenue of $20.4 million
o 2015 revenue of $2.3 million
o Maximizes revenue by capturing
additional revenue streams per patient
o Continuity of care for patients
o Helps recruit top physicians
o Increased patient & physician
satisfaction
o Improve patient outcomes
o Accretive earnings
Benefits Financial Contribution Development
19. Growth Strategy
19
1 Marketing Expertise Drives Organic Growth 2
3 4
o Continue utilizing multiple marketing channels to drive volume
growth at hospitals, ASCs, ancillary services, and physician
owned practices
o Strengthen bundled payment capabilities through efforts at
Concertis, LLC
o Strategically adding new marketing brands to portfolio
o 360 Concierge
o The market is highly fragmented with many ideal acquisition
targets for Nobilis
o Strong focus on potential targets that allow Nobilis to cross-
sell service lines
o Focused on pursuing regional in-network targets with strong
clinical and management capabilities that are sensitive to
Nobilis’ marketing platform and allow the Company to
leverage existing facilities
o Continue optimizing case mix to maximize revenue potential
o Increase the volume of high acuity procedures that benefit
from higher levels of reimbursement
o Identify and develop additional service lines appropriate for
outpatient environment
o Focus on driving cost reductions throughout system and in
recently acquired facilities
o Identify and achieve greater economies of scale as Nobilis
continues acquiring new businesses and expanding its
platform
Acquisition Opportunities
Service Lines and Specialties Operational Leverage
23. 23
Driving Efficiencies
o Reduction in force (RIF)
• Completed April 2017
• System-wide
o Payroll system/productivity tools
• Redesign/restructure of payroll
system
• Enhanced reporting
‒ Implemented daily productivity
KPI’s at each facility
‒ Controls in place to manage
hiring process
Nobilis is focused on reducing operational expenses at its facilities to further drive profitability
= Estimated $10 to $13 million in annualized cost savings à $8 million expected in 2017
Salaries and Benefits Medical Supplies SG&A
o GPO and local agreements
executed
o Custom packs/reprocessing
o Utilization
o Inventory consignment
o Physician co-marketing and direct-
to-consumer marketing
o Purchased services
o Utility contracts
$6 to $7
million
$2 to $3
million
$2 to $3
million
24. 24
Comparable Companies
Company Ticker Share Price Market Cap (mm) Forward P/E EV/EBITDA Total Debt/ Equity
Nobilis Health Corp. HLTH $1.55 $120.6 8.9 3.9 0.6
Tenet Healthcare Corp. THC $13.03 $1,310.0 13.4 8.3 40.6
CRH Medical Corp. CRHM $2.45 $185.0 18.1 8.4 0.7
Surgery Partners Inc. SGRY $10.60 $522.4 17.1 12.8 291.9
Universal Health Services Inc. UHS $107.69 $1,056.0 12.9 9.1 0.9
Envision Healthcare Corp. EVHC $51.32 $5,961.0 15.2 17.6 1.0
As of 08/14/2017
27. Nobilis Facilities
27
Facility Market Equity
Hospitals
First Nobilis Hospital Houston, TX 51%
Hermann Drive Surgical Hospital Houston, TX 54.75%
Plano Surgical Hospital Dallas, TX 100%
Scottsdale Liberty Hospital Scottsdale, AZ 75%
ASCs
First Nobilis Surgical Center (HOPD) Houston, TX 51%
Kirby Surgical Center Houston, TX 25%
Medical Park Drive Surgical Center (HOPD) Houston, TX 100%
Dallas Metro Dallas, TX 35%
Northstar Healthcare Surgery Center - Houston Houston, TX 100%
Northstar Healthcare Surgery Center - Scottsdale Scottsdale, AZ 100%
Chandler Surgery Center Phoenix, AZ 100%
Oracle Surgery Center Tucson, AZ 100%
Phoenix Surgery Center Phoenix, AZ 100%
Surprise Surgery Center Phoenix, AZ 100%
Clinics
Chandler Clinic Phoenix, AZ 100%
Oracle Clinic Tucson, AZ 100%
Phoenix Clinic Phoenix, AZ 100%
Surprise Clinic Phoenix, AZ 100%
Sugar Land Clinic Houston, TX 100%
Woodlands Clinic Houston, TX 100%
Clear Lake Clinic Houston, TX 100%
Katy Clinic Houston, TX 100%
Stone Oak Clinic San Antonio, TX 100%
Round Rock Clinic Round Rock, TX 100%
28. Facility Specialties Facility
Plano Surgical Hospital • Bariatrics • 26 Inpatient beds
• Spine • 6 OR’s
• Plastics • 2 Procedure Rooms
• Orthopedics
• General Surgery
• Pain management
Kirby Surgical Center • Orthopedics
• General surgery
• Pain
• ENT
• 4 OR’s
• 1 Procedure Room
Hermann Drive Surgical • Bariatrics • 22 Beds
Hospital • Spine • 18 Private rooms
• Plastics • 6 OR’s
• Orthopedics • 2 Procedure Rooms
• General Surgery
First Surgical Hospital • Bariatrics Hospital • 4OR’s
• 1 Procedure
Room
First Street Surgery Center • Spine
(HOPD) • Plastics
• Orthopedics
• General Surgery
ASC • 4OR’s
• Painmanagement
Northstar Healthcare Surgery • Spine • 3 ORs
Center - Houston • Bariatrics • 2 Treatment rooms
• General Surgery
• Pain
• Podiatry
• Plastics
• GI
Nobilis Facilities
28
29. Facility Specialties Facility
Northstar Healthcare Surgery • Plastics/Reconstructive • 4 OR’s
Center - Scottsdale • Orthopedics • 1 Procedure Room
• General surgery
• Pain
• Bariatrics
• Podiatry
Scottsdale Liberty Hospital • Spine • 2 OR’s
• Orthopedic surgery • 1 Procedure Room
• General surgery • 12 Inpatient beds
• Podiatry
• Bariatrics
• Migraine
• Vascular
Arizona Vein & Vascular Center • Vein • 4 Clinics
• 4 ASCs
• 15 OR’s
Hamilton Vein Center • Vein • 6 Clinics
• 20 RFAs
Nobilis Facilities
29